What is a stock summary page? Click here for an overview.
Business Description
Crescita Therapeutics Inc
NAICS : 325412
SIC : 3741
ISIN : CA2258471028
Description
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.12 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.76 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -0.77 | |||||
| Beneish M-Score | -3.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.8 | |||||
| 3-Year EPS without NRI Growth Rate | -51.7 | |||||
| 3-Year Book Growth Rate | -5.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 0.19 | |||||
| 14-Day RSI | 4.4 | |||||
| 3-1 Month Momentum % | -13.12 | |||||
| 6-1 Month Momentum % | 1757.62 | |||||
| 12-1 Month Momentum % | 21.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.77 | |||||
| Quick Ratio | 2.04 | |||||
| Cash Ratio | 1.68 | |||||
| Days Inventory | 194.97 | |||||
| Days Sales Outstanding | 34.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 3.1 | |||||
| Shareholder Yield % | 6.38 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.07 | |||||
| Operating Margin % | -16.42 | |||||
| Net Margin % | -14.05 | |||||
| FCF Margin % | 3.03 | |||||
| ROE % | -15.98 | |||||
| ROA % | -11.85 | |||||
| ROIC % | -34.47 | |||||
| 3-Year ROIIC % | 50.73 | |||||
| ROC (Joel Greenblatt) % | -58.45 | |||||
| ROCE % | -15.08 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 6.17 | |||||
| PS Ratio | 0.57 | |||||
| PB Ratio | 0.7 | |||||
| Price-to-Tangible-Book | 0.78 | |||||
| Price-to-Free-Cash-Flow | 18.13 | |||||
| Price-to-Operating-Cash-Flow | 4.11 | |||||
| EV-to-EBIT | -0.98 | |||||
| EV-to-EBITDA | -2.43 | |||||
| EV-to-Revenue | 0.14 | |||||
| EV-to-FCF | 4.22 | |||||
| Price-to-GF-Value | 0.91 | |||||
| Price-to-Projected-FCF | 0.38 | |||||
| Price-to-Net-Current-Asset-Value | 1.18 | |||||
| Price-to-Net-Cash | 3.55 | |||||
| Earnings Yield (Greenblatt) % | -102.04 | |||||
| FCF Yield % | 5.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CRRTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Crescita Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 14.172 | ||
| EPS (TTM) ($) | -0.102 | ||
| Beta | -4.83 | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 10.28 | ||
| Volatility % | 2049.47 | ||
| 14-Day RSI | 4.4 | ||
| 14-Day ATR ($) | 0.000115 | ||
| 20-Day SMA ($) | 0.3901 | ||
| 12-1 Month Momentum % | 21.72 | ||
| 52-Week Range ($) | 0.021 - 0.45671 | ||
| Shares Outstanding (Mil) | 19.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Crescita Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Crescita Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Crescita Therapeutics Inc Frequently Asked Questions
What is Crescita Therapeutics Inc(CRRTF)'s stock price today?
The current price of CRRTF is $0.39. The 52 week high of CRRTF is $0.46 and 52 week low is $0.02.
When is next earnings date of Crescita Therapeutics Inc(CRRTF)?
The next earnings date of Crescita Therapeutics Inc(CRRTF) is .
Does Crescita Therapeutics Inc(CRRTF) pay dividends? If so, how much?
Crescita Therapeutics Inc(CRRTF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers